Nanostics Launches ClarityDX Prostate Test in Alberta to Significantly Improve Prostate Cancer Screening
It provides critical support to men, aged 40 to 75, and their physicians in making more informed decisions,…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
29 Sep 23
It provides critical support to men, aged 40 to 75, and their physicians in making more informed decisions,…
29 Sep 23
The PSCA System is designed for extravascular placement to provide hemodynamic support for chronic heart failure patients without…
28 Sep 23
Together with the ARC-IM Stimulator, patients also received a wireless brain-computer interface (BCI), which enables the delivery of…
28 Sep 23
Developed in partnership with Meta, Zenni's VR Prescription Lenses are custom-built for the Meta Quest 3 and deliver…
28 Sep 23
The CITRELOCK DUO is an exciting addition to Acuitive’s portfolio and is the second in a series of…
27 Sep 23
Developed based on the company’s unique EpiSwitch 3D genomics platform, the EpiSwitch Prostate Screening (PSE) test runs alongside…
27 Sep 23
Tapestri is a single-cell measurable residual disease (MRD) test intended to provide deep genotypic and immunophenotypic insights into…
27 Sep 23
The FDA approval expands the surgical applications of MONTAGE, a unique mouldable bone putty that was previously approved…
27 Sep 23
A first-of-its-kind handheld ultrasound that delivers precise, on-the-go answers from anywhere, creating new care pathways across healthcare
27 Sep 23
Patients implanted with the Evoke System now eligible for full-body MRI scans